ReShape Lifesciences Inc (RSLS)
US$ 0.365-3.95%
Price Chart
Key Statistics
Market Cap
$ 3.14M
P/E Ratio
0.02
Revenue (TTM)
$ 7.18M
Volume
1.4M
52W High
$ 414.70
52W Low
$ 4.03
Dividend Yield
0.00%
Beta
1.94
Technicals
50-Day MA
8.9656
200-Day MA
95.4575
52 Week High
414.7
52 Week Low
4.03
About RSLS
ReShape Lifesciences Inc. provides products and services that manage and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally.
Employees
17
Headquarters
Irvine, CA
CEO
Mr. Dan W. Gladney
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg